SecBot SecBot
SECBOTREPLAY Home › Report › BCAX

BCAX · Bicara Therapeutics granted a stock option to purchase 44,175 shares to…

Bicara Therapeutics Inc. · PRESS-RELEASE filed Apr 3, 2026 at 08:30 ET

At the news

NEUTRALIMPACT 2/10

PRESS-RELEASE filed Apr 3, 2026 at 08:30 ET

Bicara Therapeutics granted a stock option to purchase 44,175 shares to a new employee as an inducement to join the company. The award was made outside of its shareholder-approved plans under the 2026 Inducement Plan, consistent with Nasdaq rules.

  • Bicara Therapeutics granted a non-qualified stock option to purchase 44,175 shares to a new employee on April 1, 2026.
  • The option has an exercise price of $20.50 per share, equal to the closing price on the grant date.
  • Vesting: 25% on first anniversary, remaining 75% over 12 equal quarterly installments.
  • Grant made under the 2026 Inducement Plan, approved by independent directors, outside shareholder-approved equity plans.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access